Methanesulfonamido-cyclohexylamine derivatives of 2,4-diaminopyrimidine as potent ALK inhibitors.
Zificsak, Craig A; Theroff, Jay P; Aimone, Lisa D; Angeles, Thelma S; Albom, Mark S; Cheng, Mangeng; Mesaros, Eugen F; Ott, Gregory R; Quail, Matthew R; Underiner, Ted L; Wan, Weihua; Dorsey, Bruce D.
Bioorg Med Chem Lett
; 21(13): 3877-80, 2011 Jul 01.
Artigo em Inglês | MEDLINE | ID: mdl-21632243
Cyclometalated Gold(III) Complexes Bearing DACH Ligands.
Synthesis of novel spiro[pyrazolo[4,3-d]pyrimidinones and spiro[benzo[4,5]thieno[2,3-d]pyrimidine-2,3'-indoline]-2',4(3H)-diones and their evaluation for anticancer activity.
Design, synthesis of novel pyranotriazolopyrimidines and evaluation of their anti-soybean lipoxygenase, anti-xanthine oxidase, and cytotoxic activities.
Synthesis, characterization and cytotoxicity studies of 1,2,3-triazoles and 1,2,4-triazolo [1,5-a] pyrimidines in human breast cancer cells.
Design, synthesis and biological evaluation of sulfonamide-substituted diphenylpyrimidine derivatives (Sul-DPPYs) as potent focal adhesion kinase (FAK) inhibitors with antitumor activity.
An appraisal on synthetic and pharmaceutical perspectives of pyrazolo[4,3-d]pyrimidine scaffold.
Design and synthesis of a series of bioavailable fatty acid synthase (FASN) KR domain inhibitors for cancer therapy.
New advances in synthesis and clinical aspects of pyrazolo[3,4-d]pyrimidine scaffolds.
Design and synthesis of novel macrocyclic 2-amino-6-arylpyrimidine Hsp90 inhibitors.
Design, synthesis, and molecular docking studies of novel pyrazolyl 2-aminopyrimidine derivatives as HSP90 inhibitors.